Personalised genetic testing and its impact to insurance

11 Jan 2017

Over recent years there has been significant growth in our ability to test for genetic conditions accompanied by exponential falls in the cost of genetic testing. The implications for modern medical practice are substantial, and the insurance industry is supportive of the many advantages genetic testing has to offer in the prevention, diagnosis and treatment of disease. Nonetheless, there is concern that policy holders may not always share risk-relevant genetic information, thereby increasing insurer’s exposure to adverse-selection.

Download full article (PDF 203 KB)

We use cookies to gather information that will help us provide the best possible service. By using this site, you are accepting our cookie policy.

In our ongoing efforts to improve the quality and relevance of our publications, we would like to know more about you.

* required fields

Interested in subscribing to our content? Visit our subscription page.